A central role for carbonic anhydrase in renal hypertrophy and interstitial fibrosis [ 2009 - 2013 ]

Research Grant

Researchers: Prof Philip Poronnik (Principal investigator) ,  Prof Joseph Casey

Brief description 1 in 3 Australians are at risk of developing kidney disease. Renal replacement therapies (dialysis and transplantation) currently cost over $1.2 billion per year. These therapies do not address the underlying cause of the disease. Much research has focused on novel strategies to reverse kidney damage with mixed success. In this project we examine a novel preventative strategy based on currently available therapeutics that may slow the progression of kidney disease.

Funding Amount $AUD 414,888.68

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant